Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Aarey Drugs & Pharmaceuticals Limited
AAREYDRUGS | NSE
88.33
INR-1.55
-1.72%
AAREYDRUGS | NSE
Loading StockChartView...
About Aarey Drugs & Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
88.33
Open
90.00
High
91.44
Low
85.39
Aarey Drugs & Pharmaceuticals Limited engages in the manufacture and sale of active pharmaceutical ingredients intermediates and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea ortho para nitro anisole 2 bromomethyl 1 and 3 dioxalane and uracile as well as active pharma ingredients such as metformin HCL mefenamic acid and doxophylline. It also offers chemicals and solvents including aeromatics chemicals chemical acids chlor alkalies glycols and glycol ethers fiber intermediates acetates and esters and chlorinated solvents as well as industrial alchols ketones amines oleochemicals intermediates olefines phosphates fertilizers monomers and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai India.
View LessAAREYDRUGS | NSE
Risk
76.0
Sharpe
1.08
Luna's Score
55/100
Recommendation
Hold
Luna says (AAREYDRUGS | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
43.2%1 month
76.0%3 months
78.8%6 months
62.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
32.75
Fwd. PE
-
Price to book
1.45
Debt to equity
0.24
Debt to assets
0.10
Ent. to EBITDA
19.38
Ent. to rev.
0.56
PEG
-
Other Fundamentals
EBITDA
42.72M
MarketCap
2.56B
MarketCap(USD)
26.59M
Div. yield
-
Op. margin
0.56
Erngs. growth
54.10
Rev. growth
149.10
Ret. on equity
3.74
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
25.99
Range1M
41.13
Range3M
41.13
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.22
Price X volume
20.83M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 19.38 | 24.85 | Cheaper |
| Ent. to Revenue | 0.56 | 11.40 | Cheaper |
| PE Ratio | 32.75 | 51.36 | Cheaper |
| Price to Book | 1.45 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 78.77 | 42.17 | Riskier |
| Debt to Equity | 0.24 | 0.35 | Cheaper |
| Debt to Assets | 0.10 | 0.17 | Cheaper |
| Market Cap | 2.56B | 290.82B | Emerging |
